Mohammad Sharif Hossain
- Microbiology top 2%
- Reproductive tract infections research 7
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Toxicology top 10%
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 11
- Ophthalmology top 5%
-
- Cancer therapeutics and mechanisms 9
-
- Urinary Tract Infections Management 7
-
- Neutropenia and Cancer Infections 5
- Drug Transport and Resistance Mechanisms 4
-
- Pharmaceutical studies and practices 4
- Co-authors
- Courtney TiffanyÉtienne DumontCaroline PerryNicole E. Scangarella-OmanAparna RaychaudhuriG SędekByron E. BatteigerDavid H. Morris
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Open Forum Infectious Diseases (5 papers)Biopharmaceutics & Drug Disposition (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Mohammad Sharif Hossain
58 papers receiving 914 citations
Peers
Comparison fields: 5 of 102
- Microbiology 189
- Molecular Medicine 121
- Toxicology 34
- Pharmacology 159
- Ophthalmology 70
Countries citing papers authored by Mohammad Sharif Hossain
This map shows the geographic impact of Mohammad Sharif Hossain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sharif Hossain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sharif Hossain more than expected).
Fields of papers citing papers by Mohammad Sharif Hossain
This network shows the impact of papers produced by Mohammad Sharif Hossain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sharif Hossain. The network helps show where Mohammad Sharif Hossain may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Sharif Hossain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 21 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 18 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2015 | 24 | |
| 15 | 2014 | 37 | |
| 16 | 2011 | 15 | |
| 17 | 2010 | 50 | |
| 18 | 2004 | 30 | |
| 19 | 2002 | 50 | |
| 20 | 1995 | 4 |
About Mohammad Sharif Hossain
Mohammad Sharif Hossain is a scholar working on Molecular Medicine, Microbiology and Pharmacology, having authored 63 papers that have together received 930 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Cancer therapeutics and mechanisms (9 papers), Reproductive tract infections research (7 papers), Urinary Tract Infections Management (7 papers), Antibiotic Resistance in Bacteria (6 papers), Neutropenia and Cancer Infections (5 papers), Pharmaceutical studies and practices (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Microbiology (189 citations), Molecular Medicine (121 citations) and Toxicology (34 citations). Mohammad Sharif Hossain has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Courtney Tiffany, Étienne Dumont, Caroline Perry, Nicole E. Scangarella-Oman, Aparna Raychaudhuri, G Sędek, Byron E. Batteiger, David H. Morris, Ann Avery and Stephanie N. Taylor. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Biopharmaceutics & Drug Disposition, Clinical and Translational Science and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.